Definition And Classification

  • A high-risk newborn belongs to risk groups including infants born prematurely, post-term, small for gestational age (SGA), or large for gestational age (LGA).
  • They are at higher risks of mortality, short-term health complications, and long-term health issues compared to babies born at term with appropriate weight for gestational age.
  • Although risk group categorization is not perfectly accurate for predicting individual poor outcomes, it allows healthcare systems to triage newborns to relevant levels of care.
  • High-risk infants require closer monitoring and structured follow-up for short-term and long-term adverse events.

Antenatal And Perinatal Risk Factors

Maternal And Personal Factors

  • Advanced maternal age over 40 years increases the risk of chromosomal abnormalities, macrosomia, fetal growth restriction (FGR), and placental blood loss.
  • Maternal age under 16 years increases the risk of FGR, preterm birth, and child abuse or neglect.
  • Poor maternal nutritional status and severe malnutrition can lead to mild FGR or fetal demise.

Obstetric And Medical Disorders

  • Pregnancy-induced hypertension links to stillbirth, FGR, preterm birth, perinatal asphyxia, polycythemia, and thrombocytopenia.
  • Gestational diabetes relates to macrosomia, birth injury, respiratory distress syndrome (RDS), and neonatal hypoglycemia.
  • Premature rupture of membranes significantly increases the risk of neonatal infection and sepsis.
  • Decreased fetal activity strongly associates with fetal demise, neurologic abnormalities, and perinatal asphyxia.
  • Meconium-stained amniotic fluid (MSAF) increases the risk of stillbirth, asphyxia, meconium aspiration syndrome (MAS), and persistent pulmonary hypertension of the newborn (PPHN).
  • Prolapsed cord, uterine tetany, and abnormal presentation increase the risk of severe birth trauma and perinatal asphyxia.
  • Obstetric analgesia and general anesthesia can cause neonatal respiratory depression and hypotension.

Specific High-Risk Groups And Associated Morbidities

High-Risk CategoryDefinitionKey Associated Morbidities
Preterm NeonatesGestation < 37 completed weeks.Respiratory problems include RDS, apnea of prematurity, and bronchopulmonary dysplasia (BPD). Neurologic issues include intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL). Cardiovascular issues include patent ductus arteriosus (PDA) and shock. Gastrointestinal issues include necrotizing enterocolitis (NEC). Ophthalmologic risks include retinopathy of prematurity (ROP).
Post-Term NeonatesGestation > 41 weeks.Increased risk of perinatal asphyxia and meconium aspiration syndrome. Metabolic risks include hypoglycemia, hypocalcemia, and polycythemia. Post-maturity syndrome manifests with dry, cracked, peeling skin and a malnourished appearance.
Fetal Growth Restriction (FGR)Fetus failing to reach predetermined growth potential.High risk of perinatal asphyxia due to acute hypoxia superimposed on chronic placental insufficiency. Poor fat stores increase hypothermia risk. Poor glycogen stores increase hypoglycemia risk. Chronic intrauterine stress leads to polycythemia. Increased risk of feed intolerance and NEC.
Infants of Diabetic Mothers (IDM)Neonates born to mothers with gestational or pregestational diabetes.High risk for postnatal hypoglycemia requiring serial glucose measurements. Macrosomia is associated with an increased risk of birth trauma including brachial plexus injury and scalp hematomas. Increased risk of polycythemia and subsequent renal vein thrombosis. Structural issues include congenital anomalies and hypertrophic cardiomyopathy.

Follow-Up Of High-Risk Neonates

  • Improving perinatal-neonatal care has increased the survival of high-risk newborns.
  • These survivors are at high risk of post-discharge morbidities including growth failure, ongoing medical illnesses, neurosensory impairment, and developmental deficits.
  • A comprehensive follow-up program ensures intact survival, optimum growth, and optimal quality of life.
  • Follow-up should be conducted in a dedicated high-risk clinic by a multidisciplinary team.
  • The team should ideally comprise a neonatologist, clinical psychologist, physiotherapist, occupational therapist, speech therapist, nutritionist, and medical social worker.

Indications For High-Risk Follow-Up

Primary Inclusion CriteriaSpecific Clinical Conditions Requiring Follow-Up
Extreme Prematurity & Low Birth WeightBirth weight < 1500 grams. Gestation < 32 weeks.
Severe Neurologic InjuryHypoxic-ischemic encephalopathy stage 2 or higher. Meningitis. Abnormal neurological examination at discharge or neonatal seizures. Grade III IVH or periventricular leukomalacia.
Respiratory MorbidityReceived mechanical ventilation for 48 hours or more. Chronic lung disease (BPD).
Severe Metabolic & Systemic IssuesIntrauterine growth < 3rd centile. Major malformations or inborn errors of metabolism. Symptomatic hypoglycemia or symptomatic polycythemia. Hyperbilirubinemia requiring exchange transfusion.

Pre-Discharge Prerequisites And Counseling

  • The neonate must be hemodynamically stable and able to maintain body temperature in an open crib.
  • The infant must be on full enteral feeds, either through direct breastfeeding or by paladai and spoon.
  • The infant must show stable weight gain for at least three consecutive days.
  • Very low birth weight infants should reach a weight of at least 1600 grams before discharge.
  • The infant must be off all medications except for vitamins and iron supplementation.
  • Preterm infants on caffeine therapy for apnea should be off treatment for at least 5 days to ensure no recurrence prior to discharge.
  • Parents must be adequately counseled regarding temperature regulation, exclusive breastfeeding, and recognition of danger signs.

Follow-Up Schedule

  • The follow-up schedule should be clearly explained to parents and documented in the discharge summary.
  • For very preterm infants, the first visit is scheduled 3 to 7 days after discharge to assess home adjustment.
  • Visits should occur every 2 weeks until the infant reaches a body weight of 3 kg.
  • Subsequent assessments are scheduled at 1, 2, 3, 6, 9, 12, 15, 18, and 24 months, and then yearly until 8 years of age.

Corrected Age Vs. Postnatal Age

  • Corrected age is the age of the child since the expected date of delivery.
  • Correction for gestational immaturity should be used until 24 months of age.
  • All anthropometric parameters, developmental milestones, and initiation of complementary feeds must be assessed according to the corrected age.
  • Postnatal age is the age of the child since birth and is strictly used for scheduling immunizations.

Domains Of Assessment During Follow-Up

Growth Monitoring

  • Serial plotting of weight, length, and head circumference on an appropriate growth chart is essential.
  • Growth monitoring allows the evaluation of extrauterine growth restriction (EUGR).

Neuromotor And Developmental Screening

  • Early identification of infants at risk for developmental disability allows for appropriate planning and parental counseling.
  • Screening should be performed routinely at 3, 6, 9, 18, and 24 months of corrected age.
  • The Hammersmith Infant Neurological Examination (HINE) is a standardized clinical neurological examination for infants between 2 and 24 months.
  • A HINE score of less than 40 is always associated with cerebral palsy.
  • A HINE score above 73 at two years of age indicates the absence of cerebral palsy.
  • At three months of age, a HINE score of less than 56 strongly predicts cerebral palsy at two years of corrected age.

Vision And Hearing Assessment

  • Retinopathy of prematurity (ROP) screening must continue until 40 to 44 weeks postconceptional age or until the retinal vessels are fully mature.
  • Children require ongoing assessment for visual problems such as strabismus and refractive errors at subsequent health supervision visits.
  • Two-stage hearing screening with otoacoustic emissions (OAE) followed by automated auditory brainstem response (AABR) may still miss some permanent hearing loss.
  • Continuous hearing follow-up is essential, especially for infants with risk factors like extreme prematurity, severe hyperbilirubinemia, or meningitis.